跳至主要内容
临床试验/JPRN-UMIN000016765
JPRN-UMIN000016765招募中2 期

Phase II Study of Vinorelbine + TS-1 in Patients with EGFR-mutated Advanced Non-small Cell Lung Cancer - Phase II Study of Vinorelbine + TS-1 in Patients with EGFR-mutated Advanced Non-small Cell Lung Cancer

Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University0 个研究点目标入组 37 人开始时间: 2015年3月11日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
37

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 Patient with need of procedure for pleural effusion 2 Patient with need of drainage procedure for cardiac effusion 3 Patient with symptomatic brain metastasis 4 Patient with severe complications5 5 Patients with interstitial pneumonia or pulmonary fibrosis diagnosed by chest X-ray 6 Female Patient in or having a chance or planning of pregnancy or breast feeding 7 Male patient in planning to impregnate 8 Patient with active multiple cancers 9 Patients with history of drug hypersensitivity 10 Patients with histoly of hypersensitivity against vinorelbine or other vinca alkaloids 11 Patients with histoly of hypersensitivity against TS-1 or pyrimidine fluoride 12 Being treated with other pyrimidine fluoride 13 Being treated with flucytosine 14 Any patients judged by the investigator to be unfit to participate in the study

研究者

发起方
Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University

相似试验